|Bid||28.30 x 0|
|Ask||28.35 x 0|
|Day's Range||28.52 - 28.52|
|52 Week Range||15.45 - 28.52|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, NY / ACCESSWIRE / January 28, 2021 / Getinge AB (OTC PINK:GNGBY) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on January 28, 2021 at 10:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
Swedish medical equipment maker Getinge is building a second production line for sterile transfer products to meet a spike in demand as COVID-19 vaccine manufacturing takes off. The maker of products for surgery, intensive care and sterilization saw a spike in demand in 2020 for ventilators and other advanced life support equipment due to the pandemic, delivering no less than 26,000 ventilators. While demand for ventilators peaked earlier in the year, it remained strong in the fourth quarter for extracorporeal membrane oxygenation (ECMO) machines, a kind of artificial lung, the company said on Thursday.
Swedish medical equipment maker Getinge <GETIb.ST> reported a jump in second-quarter core profit and orders on Thursday as demand for ventilators and other life support equipment surged due to the still raging pandemic. Getinge, one of the world's biggest makers of medical ventilators, is increasing ventilator production capacity as it expects its high delivery rate to continue into next year. "The high volumes, combined with the productivity measures in recent years, resulted in increased profitability, strengthened free cash flow and lower net debt," CEO Mattias Perjos said in a statement.